FindTrial
Sign In

Application of Vitamin D in Chronic Kidney Disease

Application of Vitamin D in Chronic Kidney Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17011447
Enrollment
Unknown
Registered
2017-05-20
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

Membranous nephropathy:Conventional treatment
Lupus nephritis:Conventional treatment
IgA nephropathy:Conventional treatment
Normal control group:Not intervene

Sponsors

Shijiazhuang kidney disease hospital limited liability company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of lupus nephritis, IgA nephropathy, membranous nephropathy in patients with chronic kidney disease; 2. No renal replacement therapy; 3. Aged 16-70 years.

Exclusion criteria

Exclusion criteria: 1. no urine; 2. limb incomplete; 3. the application of dobutamine, calcium benzenesulfonate and other factors affecting the determination of enzymatic creatinine; 4. AKI (RIFLE or AKIN standard) during the study; 5. No kidney History of transplant surgery.

Design outcomes

Primary

MeasureTime frame
Vitamin D;Urine protein quantification;—

Countries

China

Contacts

Public ContactHe Yanguang

Shijiazhuang kidney disease hospital limited liability company

1262491907@qq.com+86 15930880156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026